The Douglas Mental Health University Institute is a Canadian psychiatric hospital located in the borough of Verdun in the city of Montreal, Quebec. It is also a teaching hospital affiliated with McGill University. The nearest Montreal Metro station is Monk.

During the past decade, Douglas Mental Health University Institute conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 1 clinical trials were completed, i.e. on average, 4.8% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 1 clinical trials were completed. i.e. 8.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Douglas Mental Health University Institute" #1 sponsor was "Douglas Mental Health University Institute" with 16 trials, followed by "Lady Davis Institute" with 6 trials sponsored, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 2 trials sponsored, "McGill University" with 2 trials sponsored and "Aifred Health" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Douglas Mental Health University Institute" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 5 trials as a collaborator, "McGill University" with 3 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "Blema & Arnold Steinberg Family Foundation" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Douglas Mental Health University Institute" are "Adjustment Disorders" (3 trials), "Trauma and Stressor Related Disorders" (3 trials), "Acute Stress Disorder" (2 trials), "Alzheimer's Disease" (2 trials) and "Bipolar Disorder" (2 trials). Many other conditions were trialed in "Douglas Mental Health University Institute" in a lesser frequency.

Most popular intervention types in "Douglas Mental Health University Institute" are "Drug" (13 trials), "Behavioral" (11 trials), "Device" (6 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Propranolol" (2 trials), "Academic and Organization skills" (1 trials), "Accelerated HF-rTMS (Magstim Rapid 2 stimulator)" (1 trials) and "Atorvastatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Douglas Mental Health University Institute" are 32 trials for "All" genders.

Currently, there are NaN active trials in "Douglas Mental Health University Institute". 3 are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Douglas Mental Health University Institute, 2 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Douglas Mental Health University Institute, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 14 trials that are defined as “Not Applicable".